(Q43779477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

main subject

peripheral neuropathy

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Edward F Tierney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Gloria L Beckles

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Betsy L Cadwell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

207-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23121724%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

National trends in statin use by coronary heart disease risk category

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin-associated neuromyotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin myopathy: incidence, risk factors, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Safety issues with statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin safety and drug interactions: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin-associated rhabdomyolysis triggered by grapefruit consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Neuromuscular complications of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin safety: an overview and assessment of the data--2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Lovastatin and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

HMG-CoA reductase inhibitor therapy and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statins and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin therapy and small fibre neuropathy: a serial electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Peripheral neuropathy associated with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statin-associated peripheral neuropathy: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Advances in understanding drug-induced neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Medication-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statins and risk of polyneuropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statins may be useful in diabetic foot ulceration treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Potential therapeutic role of statins in neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Statins potentiate caspase-3 activity in immortalized murine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Four cases of tendinopathy in patients on statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Narrative review: statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013

Long-term adherence to statin treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12013